Modulation of Estrogen Chemical Carcinogenesis by Botanical Supplements used for Postmenopausal Women's Health
- PMID: 24223609
- PMCID: PMC3818722
- DOI: 10.1016/j.ddmec.2012.11.001
Modulation of Estrogen Chemical Carcinogenesis by Botanical Supplements used for Postmenopausal Women's Health
Abstract
Breast cancer risk has been associated with long-term estrogen exposure including traditional hormone therapy (HT, formally hormone replacement therapy). To avoid traditional HT and associated risks, women have been turning to botanical supplements such as black cohosh, red clover, licorice, hops, dong gui, and ginger to relieve menopausal symptoms despite a lack of efficacy evidence. The mechanisms of estrogen carcinogenesis involve both hormonal and chemical pathways. Botanical supplements could protect women from estrogen carcinogenesis by modulating key enzymatic steps [aromatase, P4501B1, P4501A1, catechol-O-methyltransferase (COMT), NAD(P)H quinone oxidoreductase 1 (NQO1), and reactive oxygen species (ROS) scavenging] in estradiol metabolism leading to estrogen carcinogenesis as outlined in Figure 1. This review summarizes the influence of popular botanical supplements used for women's health on these key steps in the estrogen chemical carcinogenesis pathway, and suggests that botanical supplements may have added chemopreventive benefits by modulating estrogen metabolism.
Figures

Similar articles
-
Botanicals and Their Bioactive Phytochemicals for Women's Health.Pharmacol Rev. 2016 Oct;68(4):1026-1073. doi: 10.1124/pr.115.010843. Pharmacol Rev. 2016. PMID: 27677719 Free PMC article. Review.
-
The Multiple Biological Targets of Hops and Bioactive Compounds.Chem Res Toxicol. 2019 Feb 18;32(2):222-233. doi: 10.1021/acs.chemrestox.8b00345. Epub 2019 Jan 22. Chem Res Toxicol. 2019. PMID: 30608650 Free PMC article. Review.
-
Hops (Humulus lupulus) inhibits oxidative estrogen metabolism and estrogen-induced malignant transformation in human mammary epithelial cells (MCF-10A).Cancer Prev Res (Phila). 2012 Jan;5(1):73-81. doi: 10.1158/1940-6207.CAPR-11-0348. Epub 2011 Oct 13. Cancer Prev Res (Phila). 2012. PMID: 21997247 Free PMC article.
-
Induction of NAD(P)H:Quinone Oxidoreductase 1 (NQO1) by Glycyrrhiza Species Used for Women's Health: Differential Effects of the Michael Acceptors Isoliquiritigenin and Licochalcone A.Chem Res Toxicol. 2015 Nov 16;28(11):2130-41. doi: 10.1021/acs.chemrestox.5b00310. Epub 2015 Nov 5. Chem Res Toxicol. 2015. PMID: 26473469 Free PMC article.
-
Red Clover Aryl Hydrocarbon Receptor (AhR) and Estrogen Receptor (ER) Agonists Enhance Genotoxic Estrogen Metabolism.Chem Res Toxicol. 2017 Nov 20;30(11):2084-2092. doi: 10.1021/acs.chemrestox.7b00237. Epub 2017 Oct 19. Chem Res Toxicol. 2017. PMID: 28985473 Free PMC article.
Cited by
-
The effects of black cohosh on the regulation of estrogen receptor (ERα) and progesterone receptor (PR) in breast cancer cells.Breast Cancer (Dove Med Press). 2018 Jan 18;10:1-11. doi: 10.2147/BCTT.S144865. eCollection 2018. Breast Cancer (Dove Med Press). 2018. PMID: 29403307 Free PMC article.
-
Preface.Drug Discov Today Dis Mech. 2012 Summer;9(1-2):e1-e3. doi: 10.1016/j.ddmec.2012.12.001. Epub 2012 Dec 22. Drug Discov Today Dis Mech. 2012. PMID: 26624611 Free PMC article. No abstract available.
-
Differential Effects of Glycyrrhiza Species on Genotoxic Estrogen Metabolism: Licochalcone A Downregulates P450 1B1, whereas Isoliquiritigenin Stimulates It.Chem Res Toxicol. 2015 Aug 17;28(8):1584-94. doi: 10.1021/acs.chemrestox.5b00157. Epub 2015 Jul 16. Chem Res Toxicol. 2015. PMID: 26134484 Free PMC article.
-
Botanicals and Their Bioactive Phytochemicals for Women's Health.Pharmacol Rev. 2016 Oct;68(4):1026-1073. doi: 10.1124/pr.115.010843. Pharmacol Rev. 2016. PMID: 27677719 Free PMC article. Review.
-
Association of Cytochrome CYP1A1 Gene Polymorphisms and Tobacco Smoking With the Risk of Breast Cancer in Women From Iraq.Front Public Health. 2018 Apr 11;6:96. doi: 10.3389/fpubh.2018.00096. eCollection 2018. Front Public Health. 2018. PMID: 29707532 Free PMC article.
References
-
- American Cancer Society. Cancer Facts & Figures 2011. American Cancer Society; 2011.
-
- Rossouw JE, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women’s Health Initiative randomized controlled trial. JAMA, J Am Med Assoc. 2002;288:321–333. - PubMed
-
- Newton KM, et al. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol. 2002;100:18–25. - PubMed
-
- Kelly JP, et al. Recent trends in use of herbal and other natural products. Arch Intern Med. 2005;165:281–286. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous